Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
MC_U120061454
Medical Research Council - United Kingdom
HL63709
NHLBI NIH HHS - United States
HL56028
NHLBI NIH HHS - United States
TW01236
FIC NIH HHS - United States
HL35018
NHLBI NIH HHS - United States
PubMed
18071061
DOI
10.1161/hypertensionaha.107.100743
PII: HYPERTENSIONAHA.107.100743
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- cholesterol metabolismus MeSH
- geneticky modifikovaná zvířata MeSH
- hypertenze komplikace genetika MeSH
- játra metabolismus MeSH
- krevní tlak fyziologie MeSH
- krysa rodu Rattus MeSH
- lokus kvantitativního znaku genetika MeSH
- mutace genetika MeSH
- potkani inbrední BN MeSH
- potkani inbrední SHR MeSH
- protein SREBP1 genetika metabolismus MeSH
- rizikové faktory MeSH
- sekvenční analýza DNA MeSH
- ztučnělá játra komplikace genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Názvy látek
- cholesterol MeSH
- protein SREBP1 MeSH
- Srebf1 protein, rat MeSH Prohlížeč
Approximately 30% of patients with hypertension have hepatic steatosis, and it has recently been proposed that fatty liver be considered a feature of the metabolic syndrome. Obesity, diet, and level of physical activity are likely factors modulating risk for hepatic steatosis, however genetic factors could also influence susceptibility or resistance to fatty liver in hypertensive or normotensive subjects. In genetic studies in spontaneously hypertensive rats (SHRs) and Brown Norway (BN) rats, we discovered that a variant form of sterol regulatory element binding transcription factor 1 (Srebf1 gene, SREBP-1 protein) underlies a quantitative trait locus (QTL) influencing hepatic cholesterol levels in response to a high cholesterol diet. Compared with the BN allele of Srebf1, the SHR allele of Srebf1 includes variants in the promoter and coding regions that are linked to hepatic deficiency of SREBP-1 mRNA and protein, reduced expression of the SREBP-1 target gene stearoyl-CoA desaturase 1, reduced promoter activity for SREBP-1c, and relative protection from dietary induced accumulation of liver cholesterol. Genetic correction of reduced SREBP-1 activity by derivation of congenic and transgenic strains of SHR increased hepatic cholesterol levels, thereby confirming Srebf1 as a QTL influencing hepatic lipid metabolism in the rat. The Srebf1 variant regulating hepatic cholesterol did not appear to affect blood pressure. These findings (1) are consistent with the results of association studies indicating that common polymorphisms affecting SREBP-1 may influence cholesterol synthesis in humans and (2) indicate that variation in Srebf1 may influence risk for hepatic steatosis.
Citace poskytuje Crossref.org
Recent advances in genetics of the spontaneously hypertensive rat